Alpro Pharmacy Launches Free Medication Program...
Several states in Malaysia are facing severe flooding after continuous monsoon rains. In response, Alpro Pharmacy, the country’s largest prescription pharmacy chain, is providing assistance to affected communities. To prevent...
Alpro Pharmacy Launches Free Medication Program...
Several states in Malaysia are facing severe flooding after continuous monsoon rains. In response, Alpro Pharmacy, the country’s largest prescription pharmacy chain, is providing assistance to affected communities. To prevent...
Malaysia Faces a Sharp Rise in Heart and Kidney...
Alpro Group, with support from Boehringer Ingelheim, launches Jaga CarDia to encourage early screening and prevention KUALA LUMPUR, MALAYSIA – 18 November 2025 – Every day, an average of 55 Malaysians...
Malaysia Faces a Sharp Rise in Heart and Kidney...
Alpro Group, with support from Boehringer Ingelheim, launches Jaga CarDia to encourage early screening and prevention KUALA LUMPUR, MALAYSIA – 18 November 2025 – Every day, an average of 55 Malaysians...
Malaysia Faces a Sharp Rise in Heart and Kidney...
Alpro Group, with support from Boehringer Ingelheim, launches Jaga CarDia to encourage early screening and prevention KUALA LUMPUR, MALAYSIA – 18 November 2025 – Every day, an average of 55 Malaysians...
马来西亚心脏与肾脏疾病病例激增
大专集团携手勃林格殷格翰推出「Jaga CarDia」计划 倡导全民早筛与预防意识 吉隆坡，马来西亚 – 2025年11月18日 – 根据马来西亚统计局（Department of Statistics Malaysia, 2022) 数据显示，每天平均有55名马来西亚人因心脏疾病去世，其中许多人正值事业与家庭的黄金时期。同时，数百万国人正默默与慢性肾病（CKD）共存，却毫不自知。 (左起: 林恩妮药剂师 (大专集团首席药剂师兼顾客互动管理总监); 江升廷医生 (大专医疗诊所家庭医生兼诊所经理)；钟维国先生 (勃林格殷格翰马来西亚、新加坡及印尼总经理兼人药部门主管); 方爱瑷女士 (勃林格殷格翰马来西亚、新加坡及印尼心肾代谢治疗领域主管)；Dr Jamal Malik (勃林格殷格翰马来西亚医学部主管) 为应对这场”无声却日益严重”的健康危机，大专集团（Alpro Group）在全球非传染性疾病管理领域的领导者勃林格殷格翰（Boehringer Ingelheim）支持下，推出全国性补贴早期筛检计划「Jaga CarDia」。该计划旨在协助5,000名长期服药的马来西亚人，以可负担的价格检测心脏、肾脏和肝脏的早期损伤迹象，在疾病仍可逆转时及时发现与干预。 「Jaga CarDia」提供涵盖心脏、肾脏、肝脏及营养健康的综合血液检测，包含70多项重要健康指标。检测配套以两人仅RM100的补贴价开放，鼓励家庭成员一同关注健康。从治疗转向预防，是大专集团与勃林格殷格翰共同推动的健康理念，希望提升大众对早期检测的重视，减少心衰、中风及洗肾等严重并发症的发生。...
